fda drug shortage list semaglutide status january 2025 declares end to Wegovy and Ozempic GLP-1 No Longer on FDA's – FDA Ends Semaglutide Shortage Listing,

Subsequent research has shown that CJC-1295 may enhance sleep, increase muscle mass, and stimulate fat loss in test subjects [1]

The choice between the two often depends on individual tolerance and specific health goals

Extrapolating from semaglutide and tirzepatide data is reasonable given shared molecular characteristics (large protein-based structures, poor oral bioavailability), but it is not the same as having direct evidence

Bruising at semaglutide injection sites occurs when the needle penetrates small blood vessels beneath the skin, triggering inflammation and bleeding into surrounding tissue

Brechner will review your situation and give you a straight answer